$20.01
-0.05-0.25%
At Close: -
$21.01
15.00%
After Hours: Jul 5, 7:13 PM EDT
15 minutes delayed
Kura Oncology
KURANASDAQ
want to know what
the Bulls & Bears Say?
Kura Oncology (NASDAQ:KURA) Stock, Analyst Ratings, Price Targets, Forecasts
Kura Oncology Inc has a consensus price target of $28.63 based on the ratings of 40 analysis. The 3 most-recent analyst ratings were released by HC Wainwright & Co., JMP Securities, and JMP Securities on June 24, 2024, June 18, 2024, and May 16, 2024, respectively. With an average price target of $32 between HC Wainwright & Co., JMP Securities, and JMP Securities, there's an implied 52.31% upside for Kura Oncology Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
JMP Securities
Wedbush
Mizuho
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for Kura Oncology
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/24/2024 | Buy Now | 52.31% | HC Wainwright & Co. | Joseph Pantginis | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 06/18/2024 | Buy Now | 52.31% | JMP Securities | Reni Benjamin | $32 → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/16/2024 | Buy Now | 52.31% | JMP Securities | Reni Benjamin | → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/14/2024 | Buy Now | 52.31% | HC Wainwright & Co. | Joseph Pantginis | — | Reiterates | Buy → Buy | Get Alert |
| 05/06/2024 | Buy Now | 52.31% | JMP Securities | Reni Benjamin | → $32 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/03/2024 | Buy Now | 76.11% | Wedbush | Robert Driscoll | → $37 | Reiterates | Outperform → Outperform | Get Alert |
| 05/03/2024 | Buy Now | 52.31% | HC Wainwright & Co. | Joseph Pantginis | → $32 | Reiterates | Buy → Buy | Get Alert |
| 04/22/2024 | Buy Now | 52.31% | HC Wainwright & Co. | Joseph Pantginis | → $32 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2024 | Buy Now | 52.31% | HC Wainwright & Co. | Joseph Pantginis | → $32 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | Buy Now | 52.31% | HC Wainwright & Co. | Joseph Pantginis | → $32 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | Buy Now | 76.11% | Wedbush | Robert Driscoll | → $37 | Reiterates | Outperform → Outperform | Get Alert |
| 01/31/2024 | Buy Now | 52.31% | JMP Securities | Reni Benjamin | $22 → $32 | Maintains | Market Outperform | Get Alert |
| 12/22/2023 | Buy Now | 23.75% | Mizuho | Mara Goldstein | → $26 | Initiates | → Buy | Get Alert |
| 12/08/2023 | Buy Now | 52.31% | HC Wainwright & Co. | Joseph Pantginis | → $32 | Reiterates | Buy → Buy | Get Alert |
| 11/03/2023 | Buy Now | 76.11% | Wedbush | Robert Driscoll | $40 → $37 | Maintains | Outperform | Get Alert |
| 10/18/2023 | Buy Now | 90.39% | Wedbush | Robert Driscoll | → $40 | Reiterates | Outperform → Outperform | Get Alert |
| 09/07/2023 | Buy Now | 42.79% | Cantor Fitzgerald | Li Watsek | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 08/11/2023 | Buy Now | 47.55% | B of A Securities | Jason Zemansky | → $31 | Initiates | → Buy | Get Alert |
| 07/27/2023 | Buy Now | -50.02% | Scotiabank | George Farmer | → $10.5 | Initiates | → Sector Perform | Get Alert |
| 07/21/2023 | Buy Now | 42.79% | Cantor Fitzgerald | Li Watsek | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 06/13/2023 | Buy Now | 42.79% | Cantor Fitzgerald | Li Watsek | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 06/13/2023 | Buy Now | 4.71% | JMP Securities | Reni Benjamin | → $22 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/12/2023 | Buy Now | 52.31% | HC Wainwright & Co. | Joseph Pantginis | → $32 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2023 | Buy Now | 18.99% | Stifel | Bradley Canino | $24 → $25 | Maintains | Buy | Get Alert |
| 05/17/2023 | Buy Now | 47.55% | BTIG | Justin Zelin | → $31 | Initiates | → Buy | Get Alert |
| 05/11/2023 | Buy Now | 23.75% | Credit Suisse | Tiago Fauth | → $26 | Reiterates | Outperform → Outperform | Get Alert |
| 05/11/2023 | Buy Now | 52.31% | HC Wainwright & Co. | Joseph Pantginis | → $32 | Reiterates | Buy → Buy | Get Alert |
| 04/17/2023 | Buy Now | 4.71% | JMP Securities | Reni Benjamin | → $22 | Reiterates | → Market Outperform | Get Alert |
| 02/24/2023 | Buy Now | 52.31% | HC Wainwright & Co. | Joseph Pantginis | → $32 | Reiterates | → Buy | Get Alert |
| 02/10/2023 | Buy Now | 52.31% | HC Wainwright & Co. | Joseph Pantginis | → $32 | Reiterates | → Buy | Get Alert |
| 01/31/2023 | Buy Now | 18.99% | Stifel | Bradley Canino | → $25 | Initiates | → Buy | Get Alert |
| 07/13/2022 | Buy Now | 38.03% | Credit Suisse | Tiago Fauth | $27 → $29 | Maintains | Outperform | Get Alert |
| 07/12/2022 | Buy Now | 42.79% | Cantor Fitzgerald | Li Watsek | → $30 | Initiates | → Overweight | Get Alert |
| 02/25/2022 | Buy Now | 28.51% | Credit Suisse | Tiago Fauth | $25 → $27 | Maintains | Outperform | Get Alert |
| 02/25/2022 | Buy Now | 33.27% | SVB Leerink | Jonathan Chang | $41 → $28 | Maintains | Outperform | Get Alert |
| 02/15/2022 | Buy Now | 66.59% | Jefferies | Roger Song | → $35 | Initiates | → Buy | Get Alert |
| 11/26/2021 | Buy Now | -0.05% | Credit Suisse | Tiago Fauth | — | Maintains | Outperform | Get Alert |
| 11/24/2021 | Buy Now | 52.31% | HC Wainwright & Co. | Joseph Pantginis | $43 → $32 | Maintains | Buy | Get Alert |
| 08/06/2021 | Buy Now | 90.39% | Credit Suisse | Tiago Fauth | — | Maintains | Outperform | Get Alert |
| 08/06/2021 | Buy Now | 95.15% | SVB Leerink | Jonathan Chang | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Kura Oncology (KURA) stock?
The latest price target for Kura Oncology (NASDAQ:KURA) was reported by HC Wainwright & Co. on June 24, 2024. The analyst firm set a price target for $32.00 expecting KURA to rise to within 12 months (a possible 52.31% upside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kura Oncology (KURA)?
The latest analyst rating for Kura Oncology (NASDAQ:KURA) was provided by HC Wainwright & Co., and Kura Oncology reiterated their buy rating.
When was the last upgrade for Kura Oncology (KURA)?
There is no last upgrade for Kura Oncology
When was the last downgrade for Kura Oncology (KURA)?
There is no last downgrade for Kura Oncology.
When is the next analyst rating going to be posted or updated for Kura Oncology (KURA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kura Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kura Oncology was filed on June 24, 2024 so you should expect the next rating to be made available sometime around June 24, 2025.
Is the Analyst Rating Kura Oncology (KURA) correct?
While ratings are subjective and will change, the latest Kura Oncology (KURA) rating was a reiterated with a price target of $32.00 to $32.00. The current price Kura Oncology (KURA) is trading at is $21.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.